Ypsomed Holding AG (XSWX:YPSN) Moat Score: 7/10 (As of Jul. 03, 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF360.60
GF Value CHF397.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Moat Score?

Ypsomed Holding AG XSWX:YPSN -0.66% 92 Moat Score is 7 as of Jul. 03, 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF397.15 (Fairly Valued). The stock has 4 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 98.93% on this metric.

Ypsomed Holding AG has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Ypsomed Holding AG has Ypsomed Holding AG benefits from strong intellectual property and innovation in the medical technology sector. It has a robust distribution network and customer loyalty. However, competition and regulatory challenges limit its moat to a narrow to moderate level.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Ypsomed Holding AG might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Ypsomed Holding AG  (XSWX:YPSN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Ypsomed Holding AG Moat Score Related Terms

XSWX:YPSN vs ISRG, BDX, MDLN: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Moat Score falls into.


XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Ypsomed Holding AG (XSWX:YPSN) has a Moat Score of 7 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Ypsomed Holding AG ranks #9 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Ypsomed Holding AG's Moat Score too high?
Ypsomed Holding AG's current Moat Score is 7. Based on the distribution chart, Ypsomed Holding AG ranks #9 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Moat Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #9 out of 845 companies for Moat Score. This places Ypsomed Holding AG in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Ypsomed Holding AG's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.15, compared to a current price of CHF360.60 — trading 9.2% below its estimated fair value. The current Moat Score is 7. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Moat Score is 7 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF360.60 is trading 9.2% below its estimated GF Value™ of CHF397.15. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Moat Score: 7
  • GF Value™: CHF397.15 vs. price of CHF360.60 (9.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF360.60
Price
CHF397.15
GF Value